impact factor, citescore
logo
 

Full Papers

 

Factors associated with endomysial fibrosis in anti-signal recognition particle antibody immune-mediated necrotising myopathy


1, 2, 3, 4, 5, 6, 7, 8, 9

 

  1. Department of Neurology, Peking University First Hospital, Beijing, China.
  2. Department of Neurology, Peking University First Hospital, Beijing; and Department of Neurology, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
  3. Department of Neurology, Peking University First Hospital, Beijing, China.
  4. Department of Neurology, Peking University First Hospital, Beijing, China.
  5. Department of Neurology, Peking University First Hospital, Beijing, China.
  6. Department of Neurology, Peking University First Hospital, Beijing, China.
  7. Department of Neurology, Peking University First Hospital, Beijing; Beijing Key Laboratory of Neurovascular Disease Discovery, Beijing; and Rare Disease Medical Center, Peking University First Hospital, Beijing, China.
  8. Department of Neurology, Peking University First Hospital, Beijing; Beijing Key Laboratory of Neurovascular Disease Discovery, Beijing; and Rare Disease Medical Center, Peking University First Hospital, Beijing, China.
  9. Department of Neurology, Peking University First Hospital, Beijing, China. 18813187041@163.com

CER19077
Full Papers

Free to view
(click on article PDF icon to read the article)

PMID: 41562357 [PubMed]

Received: 06/07/2025
Accepted : 12/12/2025
In Press: 19/01/2026

Abstract

OBJECTIVES:
Anti-signal recognition particle antibody immune-mediated necrotising myopathy (anti-SRP-IMNM) is characterised by prominent muscle weakness and poor neurological outcomes. This study aimed to evaluate the relationship between endomysial fibrosis and the clinical, muscle magnetic resonance imaging (MRI) and myo-pathological features of patients with anti-SRP-IMNM.
METHODS:
We collected the clinical, imaging, and myo-pathological data of patients diagnosed with anti-SRP-IMNM. Differences between patients with and without increased endomysial fibrosis on muscle biopsy were compared.
RESULTS:
Ninety-four patients were included in the study, comprising 12 paediatric and 82 adult patients. The mean age at onset was 41.2±17.3 years. The mean serum creatinine kinase concentration was 6885.8±6300.7 IU/L. MRI revealed muscle oedema in 87.3% of patients and fatty infiltration in 77.5%, which was particularly severe in the muscles of the posterior thigh. Endomysial fibrosis was found in 50% of patients and was significantly associated with early onset (p=0.004), paediatric age (p=0.044), muscle fatty infiltration on MRI of the thigh (p=0.045), and inflammatory cell infiltration on pathology (p<0.05).
CONCLUSIONS:
In anti-SRP-IMNM, endomysial fibrosis may be the pathological basis of fatty infiltration observed on MRI and may be associated with resistance to immunotherapy.

DOI: https://doi.org/10.55563/clinexprheumatol/bzpse1

Rheumatology Article

Rheumatology Addendum